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Abstract
Background: Globally, moderate acute malnutrition (MAM) and severe acute malnutrition (SAM) affect
approximately 52 million children under five. This systematic review evaluates the effectiveness of interventions for
SAM including the World Health Organization (WHO) protocol for inpatient management and community-based
management with ready-to-use-therapeutic food (RUTF), as well as interventions for MAM in children under five
years in low- and middle-income countries.
Methods: We systematically searched the literature and included 14 studies in the meta-analysis. Study quality was
assessed using CHERG adaptation of GRADE criteria. A Delphi process was undertaken to complement the
systematic review in estimating case fatality and recovery rates that were necessary for modelling in the Lives
Saved Tool (LiST).
Results: Case fatality rates for inpatient treatment of SAM using the WHO protocol ranged from 3.4% to 35%. For
community-based treatment of SAM, children given RUTF were 51% more likely to achieve nutritional recovery
than the standard care group. For the treatment of MAM, children in the RUSF group were significantly more likely
to recover and less likely to be non-responders than in the CSB group. In both meta-analyses, weight gain in the
intervention group was higher, and although statistically significant, these differences were small. Overall limitations
in our analysis include considerable heterogeneity in many outcomes and an inability to evaluate intervention
effects separate from commodity effect. The Delphi process indicated that adherence to standardized protocols for
the treatment of SAM and MAM should have a marked positive impact on mortality and recovery rates; yet, true
consensus was not achieved.
Conclusions: Gaps in our ability to estimate effectiveness of overall treatment approaches for SAM and MAM
persist. In addition to further impact studies conducted in a wider range of settings, more high quality program
evaluations need to be conducted and the results disseminated.
Introduction
Globally, approximately 33 million children under five
years of age are affected by moderate acute malnutrition
(MAM), defined as a weight-for-height z-score (WHZ)
between -2 and -3, and at least 19 million children
under five by severe acute malnutrition (SAM), defined
as a WHZ of <-3 [1,2]. For children with SAM, the risk
of death is approximately 10-fold higher compared to
children with a z-score ≥ – 1 [3]. Based on an analysis
by UNICEF, WHO and the World Bank [2], 32 of 134
countries for which there was data on prevalence of
acute malnutrition (WHZ <-2) had a prevalence of 10%
or more – a threshold that represents a “public health
emergency requiring immediate intervention” [2]. This
analysis also showed that, since 1990, prevalence rates
of wasting (acute malnutrition, WHZ <-2) have declined
* Correspondence: zulfiqar.bhutta@aku.edu
1Centre for Global Child Health, The Hospital for Sick Children, Toronto, ON,
Canada
Full list of author information is available at the end of the article
Lenters et al. BMC Public Health 2013, 13(Suppl 3):S23
http://www.biomedcentral.com/1471-2458/13/S3/S23
© 2013 Lenters et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
three times more slowly than for stunting (chronic
malnutrition, height-for-age z-score <-2), decreasing by
11% and 35% respectively.
SAM inpatient management guidelines have been pub-
lished by the World Health Organization (WHO), and
updates to the protocol are pending [1,4]. Practitioners
and WHO experts endorse community-based manage-
ment for uncomplicated SAM while still advising that
children who are severely malnourished and have medi-
cal complications, such as severe oedema, should be
treated in an appropriate health facility [1,5]. With
respect to the management of MAM, there are several
published guiding documents [6-8] and there is ongoing
interaction among researchers, practitioners and policy
makers; however, there is currently no standardized
approach to the management of MAM.
Since the early 2000s, the products used to deliver
nutrients for management of SAM and MAM and the
approaches used to target and deliver these products
have been evolving rapidly. Innovations include new for-
mulations and packaging and a shift from institutional
to community-based management. Specially formulated
foods are the cornerstone of treatment programs and
include fortified blended foods (e.g. corn-soy blend
(CSB)) as well as ready-to-use-foods (RUFs). RUFs are
nutrient-dense products that are formulated as lipid
pastes, bars or biscuits that provide specified amounts
high quality of protein, energy and micronutrients,
depending on the target population [9]. Detailed sum-
maries of RUF types have been described elsewhere [7].
Specific aspects of inpatient management of SAM, for
example approaches to treating infectious, IV fluid for
shock, management of diarrhea in SAM and manage-
ment of micronutrient deficiencies [10] as well as anti-
biotic use in SAM management [11,12] have been
reviewed. Nonetheless, there has not been a systematic
review of the WHO protocol in its entirety, compared
to standard care. This is essential for understanding
whether the protocol is effective as a package. In 2008, a
preliminary review of approaches to treat SAM was
undertaken for the Lancet Maternal and Child Undernu-
trition Series [13]; however, this review included more
broadly defined cases of undernutrition, was not specific
to children under five years, and included trials of vari-
able quality and methods.
Two recently published Cochrane reviews have also
investigated specially formulated foods for treating chil-
dren with MAM [14] and SAM [15] and RUTF for
home-based treatment of SAM in children 6 months to
5 years of age [15], and while the details of the analyses
vary somewhat, the overall conclusions are congruous
with the analyses presented here. Other reviews of com-
munity-based management of SAM as well as manage-
ment of MAM have been conducted [16-18]; however,
these reviews typically did not include meta-analyses
and included studies using definitions of malnutrition,
such as weight-for-age, which are not all specific to
acute malnutrition.
We undertook a systematic review in order to evaluate
the effectiveness of approaches to managing SAM,
including the WHO protocol for inpatient management
[4] and community-based management using RUTF [5],
as well as the effectiveness of approaches to managing
MAM. Our review focused on children under five in
low- and middle-income countries. In addition, we
aimed to identify gaps in the literature and to generate
the effect estimates necessary for including these inter-
ventions in the Lives Saved Tool (LiST). LiST models
the reduction in child deaths by specific causes asso-
ciated with increasing coverage of individual interven-
tions. Recent mortality rates and cause of death data for
newborns, infants, and children are incorporated, by
country, using estimates established by the Child Health
Epidemiology Group (CHERG) [19].
Methods
Searches
We developed comprehensive search strategies for the
following databases: Medline, Embase, Web of Science,
WHO regional databases and the Cochrane library (see
additional file 1). We conducted hand searches for
sources of grey literature, including the Emergency
Nutrition Network and Epicentre websites, Grey Litera-
ture Review and the World Bank website. We also
issued a call to key non-governmental organizations
requesting reports from their programs.
Literature published after 1970 was included and we
did not restrict by language. Searches were conducted
between October 9, 2012 and November 3, 2012. We
did not limit by study design type or by publication type
when selecting studies for inclusion. However, we
excluded before-and-after studies in the meta-analysis,
as we were not confident in the abilities of these studies
to isolate the intervention effect separately from the
confounding variables.
We defined MAM as weight-for-height z-score
(WHZ) between -2 and -3 standard deviations (SD),
weight-for-height (WFH) 70-80% of the NCHS or WHO
reference median or mid-upper arm circumference
(MUAC) of 115-125mm. We defined SAM as weight-
for-height z-score (WHZ) <-3 SD, weight-for-height
(WFH) <70% of the median NCHS or WHO reference
or mid-upper arm circumference (MUAC) <115mm or
oedema [4].
We contacted authors who used alternative definitions
of acute malnutrition or in cases where there was insuf-
ficient information available in the publications to
request additional information or disaggregated data. An
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asterisk next to the authors’ names in the forest plots
indicates the use of unpublished data.
Data synthesis and quality assessment
We coded and categorized the types of interventions in
each article. For moderate acute malnutrition, we con-
ducted a meta-analysis only on ready-to-use-supplemen-
tary food (RUSF) compared with CSB, as this was the
only comparison with multiple studies that could be
pooled. Likewise, for severe acute malnutrition, we con-
ducted a meta-analysis on RUTF compared with standard
therapy. No study has included true control groups using
placebo or no intervention for ethical reasons. We also
conducted a meta-analysis on two studies comparing
inpatient treatment to ambulatory treatment for children
with SAM and MAM, as well as a meta-analysis compar-
ing locally-produced RUTF to imported RUTF for rehabi-
litation of children with SAM.
We included outcomes needed for LiST and those
routinely used for program monitoring. These include:
mortality, recovery rate (as defined by authors), relapse
rate (as defined by authors), default rate, time to recov-
ery, and change in anthropometric measures such as
weight, height, MUAC and WHZ. Outcomes with more
than one data point were included in the final analysis.
We used a standardized data abstraction form to col-
lect information regarding study characteristics, descrip-
tions of the interventions and comparisons, outcomes of
interest and effects as well as quality of the studies. We
assessed quality based on the CHERG adaptation of the
GRADE technique at the individual study level and at
the outcome level [20]. Studies were classified as high,
moderate, low or very low quality. The quality of each
study was assessed based on study design, methods and
generalizability.
Quality assessment at the outcome level was graded
based on volume and consistency of the evidence,
strength of the pooled effect and strength of statistical
evidence based on the p-value. Levels of heterogeneity
were assessed by visual inspection, looking for overlap-
ping confidence intervals, and by the I2 value. An I2
value of >50% was considered to be evidence of substan-
tial heterogeneity.
The meta-analysis was conducted using RevMan 5.2®.
We applied generic inverse variance methods to all ana-
lyses and used a random effects model in all cases; sum-
mary estimates are presented as relative risk (RR) or
mean difference (MD) and 95% confidence intervals (CI).
Results
Our search identified 10,557 titles. Screening of these
titles, full text review and data abstraction was done
independently by two team members and then matched.
Any disagreements were resolved through discussion or,
where necessary, through consultation with a third team
member. After screening titles and abstracts retrieved by
our search, 10 310 articles were excluded as clearly
unrelated. The full-texts of 247 papers were screened
and 26 papers were identified to meet the inclusion cri-
teria. Twelve studies were subsequently omitted from
the meta-analysis as we could not pool their interven-
tions and/or there was insufficient data on any out-
comes of interest. A total of 14 studies were included in
the final meta-analysis (see figure 1).
The results have been categorized by intervention
type, and whether severe or moderate acute malnutri-
tion was addressed. All of the trials were situated in
areas of protracted food insecurity where wasting is
endemic. While prevalence of wasting will certainly
respond to fluctuating environmental factors, none of
the studies represented a situation of sudden and acute
starvation. Forest plots for mortality, recovery rate and
weight gain are presented in the text; however, all forest
plots can be found in additional file 2.
Community-based management of severe acute
malnutrition: Therapeutic feeding with RUTF vs. standard
therapy
Three articles, representing two unique trials, were
located that compared community-based management
with RUTF versus standard therapy in children with
severe acute malnutrition [21-23]. Standard therapy
entailed treatment in an inpatient facility until complica-
tions resolved, with the subsequent provision of Corn-
Soy blend (CSB) for feeding the child at home. Both
were quasi-experimental trials set in Malawi. In one
trial, all children were treated for infectious and meta-
bolic complications in a nutritional rehabilitation unit;
they were enrolled into the trial upon discharge and
given either RUTF or CSB for home-treatment [21,23].
The other trial enrolled children upon discharge from a
nutritional rehabilitation unit as well as directly from
the community. All of the children in the standard ther-
apy group and about half of the children in the RUTF
group had received inpatient treatment [22]. The first
did not test children for HIV, but presumably included
a mix of children who were HIV-infected and HIV-
uninfected and took place from 2002 to 2003 [22]. The
other two articles reported data from the same trial,
which took place in 2001. One reported data on the
HIV-infected cohort [23], while the other reported data
for children who were HIV-uninfected [21]. We assessed
the quality of the studies as moderate/low [22] and
moderate/high [21,23].
There were no significant differences in mortality (figure
2). Children who received RUTF were 1.51 times more
likely to recover (defined as attaining WHZ ≥ -2) than
those receiving standard therapy (RR: 1.51, 95% 1.04 to
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2.20) (figure 3). There was substantial heterogeneity (I2 =
92%), the effect was only marginally statistically significant,
and this outcome was graded as low quality (see table 1 for
quality assessment). Children who received RUTF had a
greater average height gain (MD: 0.14, 95% CI 0.05 to
0.22) and MUAC gain (MD: 0.11, 95% CI 0.05 to 0.18);
both outcomes were graded as moderate/low quality.
Average weight gain in the RUTF group was also greater
(MD: 1.27, 95% CI 0.16 to 2.38) and this outcome was
graded as moderate quality (figure 4).
Figure 1 Flow diagram showing identification of studies included in the review
Figure 2 Forest plot for the effect of RUTF vs. standard (std) therapy on mortality in SAM
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Facility-based management of severe acute malnutrition:
WHO protocol for inpatient management of SAM vs.
standard care
A literature review by Schofield and Ashworth [24] indi-
cates that between the 1950s and 1990s, case fatality
rates (CFR) were typically 20-30% among children treated
for SAM in hospitals or rehabilitation units. Average CFR
was higher (50-60%) among children with oedematous
malnutrition. The persistence of high CFR was attributed
to faulty case management, and the authors called for
prescriptive treatment guidelines as part of a comprehen-
sive training program. In the 2008 Lancet Maternal and
Child Undernutrition Series, the preliminary review esti-
mated that treating children according to the WHO
Protocol compared to standard care would result in a
48% reduction in deaths (RR 0.52, 95% CI 0.43, 0.64)
[13]. This was used in the model to determine impact on
mortality for SAM but requires refinement for the rea-
sons mentioned in the introduction.
In terms of recent studies, we found one before/after
study [25], two retrospective chart reviews [26,27], one
quasi-experimental study [28] and four prospective
cohorts [29-33] that examined the case fatality rates and
recovery rates of children with SAM treated according
to the WHO protocol or an adapted WHO protocol.
There was also one cluster RCT that compared inpatient
treatment to home-care and day-care treatment [34,35];
this study contained methodological issues and did not
Figure 3 Forest plot for the effect of RUTF vs. standard therapy on recovery in SAM
Table 1 Severe acute malnutrition: quality assessment of evidence at the category level





















of effect, I2 = 0
Children 10-60 months
presenting to nutrition
rehabilitation units in Malawi
25 15 0.77 (0.40,
1.50)








degree, I2 = 92%
Children 10-60 months
presenting to nutrition
rehabilitation units in Malawi
148 155 1.51 (1.04,
2.20)







of effect, I2 = 40%
Children 10-60 months
presenting to nutrition
rehabilitation units in Malawi
N/A N/A 0.14 (0.05,
0.22)







of effect, I2 = 0
Children 10-60 months
presenting to nutrition
rehabilitation units in Malawi
N/A N/A 0.11 (0.05,
0.18)








degree, I2 = 49%
Children 10-60 months
presenting to nutrition
rehabilitation units in Malawi
N/A N/A 1.27 (0.16,
2.38)





and 1 low quality
study
Consistent direction of
effect, I2 = 0%
Children 6-60 months presenting
to feeding clinics, studies in
Malawi and Senegal
N/A N/A 0.53 (-0.57
to 1.63)
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adequately describe the intervention (see additional file
3 for study assessment).
None of the studies provided sufficient information to
ensure that each step of the WHO protocol was followed
and many noted variations from the protocol. One study
[31,32] excluded children with severe complications and
thus may not be generalizable. Case fatality rates ranged
from 3.4% to 35% (see table 2). The highest CFR
stemmed from a cohort of HIV-infected children [31,32],
while the lowest rate was achieved in a study that pro-
vided few details on the protocol followed [34]. Only two
studies provided information on recovery rates, which
were 79.7% and 83.3%, respectively [28,31,32].
Ashworth noted that issues of training were para-
mount to improving outcomes, as mortality rates
increased with the influx of new, untrained doctors into
Figure 4 Forest plot for the effect of RUTF vs. standard therapy on weight gain in SAM
Table 2 Characteristics of studies reporting case fatality for inpatient treatment of SAM according to WHO protocol
Study Country Study
Design





Bachou 2008 Uganda Before and
after
Improved practice to reduce
unnecessary blood transfusions and
IV infusions was in accordance with
the WHO guidelines
Micronutrients and parenteral antibiotics given in
accordance with Ministry of Health
recommendations; measles vaccine and sensory
stimulation not mentioned
25%
Berti 2008 Ethiopia Retrospective
cohort
Treated according to adapted
UNICEF (2004) guidelines
Not clear if micronutrient supplementation aligns










accordance with Malawi Ministry of
Health guidelines (2003), adapted
from WHO guidelines (2003)
HIV-infected children not given ART; unclear
approach to rehydration, provision of
micronutrients, antibiotics and sensory stimulation;





Hossain 2009 Bangladesh Quasi-
experimental
Treated according to WHO protocol Protocol not described 7%
Manary 2000 Malawi Prospective
cohort
Treated according to 1971 WHO
standards
Children fed at slower rate; did not use ReSoMal
ORS; included an additional intensive nursing






Treated according to WHO
guidelines insofar as staffing allowed
Fed at a higher rate initially; authors state that
WHO protocol used but not described in detail.
19%
Ahmed 1999 Bangladesh Prospective
cohort
Adapted WHO criteria Children fed at slower rate; all children had






Bangladesh cRCT Protocol not described High risk of bias with respect to randomization;








Managed according to WHO
guidelines insofar as staffing
permitted
Age range of children not given; unclear if all
children have SAM as defined by WHO
24%
WHO: World Health Organization
UNICEF: United Nations Children’s Fund
HIV: Human immunodeficiency virus
cRCT: Cluster randomized controlled trial
WFH: weight-for-height
WFA: weight-for-age
ORS: oral rehydration solution
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a hospital [29]. Two additional observational studies
documented that implementing changes to dietary and
clinical management did not seem to be sufficient to
promote substantial reductions in case fatality rates. Key
factors associated with improved outcomes were related
to quality of care and institutional culture, including
staff morale, attentiveness of nurses and support struc-
tures at the managerial level [36,37].
Community-based management of moderate acute
malnutrition: Supplementary feeding with RUSF vs. CSB
Our review identified five studies investigating the effect
of Ready-to-Use Supplementary Food (RUSF) compared
to Corn Soy Blend (CSB) in moderately malnourished
children under five years of age [38-42]. Two of the stu-
dies were cluster randomized controlled trials (cRCTs),
one set in 10 health centres and health posts in the
Sidama zone of Ethiopia [39] and the other in the Dioila
health district in Mali [38]. Three of the studies were
randomized controlled trials (RCTs). Two were located
in southern Malawi [40,41], and one in the Zinder
region of southern Niger [42]. Two studies took place
from 2007 to 2008 [38,42]; the remaining three studies
took place during 2009 and 2010 [39-41]. We assessed
the quality of the studies to be low [42], moderate [38],
moderate/high [39,40] and high [41] quality (see addi-
tional file 3).
There were no significant differences in mortality for
children given RUSF compared to those who received
CSB (figure 5). However, the non-response rate was sig-
nificantly lower in the RUSF group (RR: 0.65, 95% CI
0.47 to 0.90). This outcome has considerable heteroge-
neity (I2 = 57%) and was graded as moderate quality
(see table 3). Children in the RUSF group were also sig-
nificantly more likely to recover (RR: 1.11, 95% CI 1.04
to 1.18), although this estimate contained substantial
heterogeneity and was graded as moderate/low quality
(figure 6). The rate of height gain did not differ between
the intervention and comparison groups. Children who
received RUSF had an average MUAC gain of 0.04 mm
per day (MD: 0.04, 95% CI 0.01 to 0.07) and had an
average weight gain of 0.61 g/kg/d higher (MD: 0.61,
95% CI 0.24 to 0.99) than those who received CSB
(figure 7). Upon discharge or completion of the study,
children who received RUSF had an average weight-for-
height z-score that was 0.11 z-scores greater than those
who received CSB (MD: 0.11, 95% CI 0.04 to 0.17).
While this is statistically significant, it may not be a suf-
ficient difference to be clinically important. Nackers et
al. [42] followed-up with children 6 months post-inter-
vention. There were no significant differences in sus-
tained recovery (defined as maintaining WFH ≥ 80% of
the NCHS median post-treatment) or height gain.
The comparison groups in two of the studies used stan-
dard CSB [39,41]. Two of the studies used “CSB++”,
which contains a revised micronutrient profile and con-
tains higher quality protein through the addition of milk
powder [38,40] and the last study used “CSB-based pre-
mix”, which contains additional oil and sugar [42]. We
performed a sensitivity analysis, separating out studies
using improved CSB (CSB++ and CSB-based pre-mix)
from those using standard CSB. For mortality, the two stu-
dies using improved-CSB slightly favoured the comparison
group, while the study using standard CSB favoured the
intervention group. For the rate of height gain, there is a
very slight difference in the direction of effect, but again
there was no significant difference between the subgroups.
The remaining outcomes showed consistent directions of
effect. There were no significant differences between the
subgroups for any outcomes.
Severe acute malnutrition: Local vs. imported RUTF
Two trials, one in Senegal, graded as low quality [43]
and the other in Malawi, graded as moderate quality
[44], compared imported RUTF to locally produced
RUTF used in community-based management of SAM.
There was no significant difference in weight gain
between intervention groups (figure 8). This effect was
consistent (I2 = 0%) and the overall outcome was graded
as moderate/low quality.
Figure 5 Forest plot for the effect of RUSF vs. CSB on mortality in MAM
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Severe and moderate acute malnutrition: Inpatient vs.
ambulatory care
Two studies compared home-based treatment to inpati-
ent treatment in children without severe complications.
One moderate quality study in Niamey, Niger, enrolled
children with MAM and SAM who were about to be
discharged from the hospital [45]. The other study,
graded as low quality, allocated children presenting to the
nutrition unit in Dhaka, Bangladesh, to receive either
home-based or inpatient care [35]. A third arm of this
trial, day care, was not analyzed because it could not be
pooled.
Table 3 Moderate acute malnutrition: quality assessment of evidence at the category level














Mortality: Moderate/high outcome specific quality Risk Ratio
4 RCT/
cRCT
1 high, 2 moderate/high
and 1 low quality study
1 of 3 studies shows
beneficial effect, I2=0%
Children 6-60 months presenting
to health centres with MAM, all
in Africa
30 20 0.92 (0.52
to 1.64)
Non-response rate: Moderate outcome specific quality Risk Ratio
4 RCT/
cRCT
1 high, 2 moderate/high




Children 6-60 months presenting
to health centres with MAM, all
in Africa
176 312 0.65 (0.47
to 0.90)
Recovery rate: Moderate/low outcome specific quality Risk Ratio
5 RCT/
cRCT
1 high, 2 moderate/high,






Children 6-60 months presenting
to health centres with MAM, all
in Africa
2,992 1,918 1.11 (1.04
to 1.18)
Rate of height gain: Moderate outcome specific quality Mean Difference




Children 6-60 months presenting
to health centres with MAM, all
in Africa
N/A N/A -0.00 (-0.02
to 0.02)
Rate of MUAC gain: Moderate outcome specific quality Mean Difference




Children 6-60 months presenting
to health centres with MAM, all
in Africa
N/A N/A 0.04 (0.01
to 0.07)
Rate of weight gain: Moderate/low outcome specific quality Mean Difference
3 RCT 1 moderate/high, 1




Children 6-60 months presenting
to feeding centers with MAM, all
in Africa
N/A N/A 0.61 (0.24
to 0.99)
Weight-for-height z-score change at completion or discharge: Moderate/low outcome specific
quality
Mean Difference




Children 6-60 months presenting
to feeding centres with MAM, all
in Africa
N/A N/A 0.11 (0.04
to 0.17)
(c)RCT: (cluster-) randomized controlled trial
Figure 6 Forest plot for the effect of RUSF vs. CSB on recovery in MAM
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There was no significant difference in mortality between
home-based or inpatient care (figure 9). However, the stu-
dies produced opposite directions of effect and the overall
quality of this outcome was rated as very low due to issues
with study design, analysis and availability of key study
details (table 4).
Results from additional studies not included in meta-
analysis
We identified several interesting singular studies that
could not be pooled in the meta-analysis. Oakley et al.
[46] studied the effect of an RUTF consisting of 25%
milk versus another with 10% milk in treating children
with SAM, and found that the RUTF with the higher
milk content was associated with a statistically signifi-
cant higher recovery rate (p<0.05). A trial in urban
Senegal randomized children with SAM and MAM to
receive RUTF or F100 (a therapeutic milk-based product
used for nutritional rehabilitation in inpatient facilities)
[47]. The study found a statistically significant difference
in the rate of weight gain: children who received RUTF
gained an average of 5.50 g/kg/d more than those
receiving F100 (MD: 5.50, 95% CI 3.00 to 8.00). Branger
et al. [48] investigated the effect of adding spirulina, a
microscopic algae to standard treatment or standard
treatment plus fish for children with moderate and
severe malnutrition in Burkina Faso. The authors found
no significant differences between treatment groups.
Navarro-Colorado [49] found no significant differences
in duration of rehabilitation or weight gain in children
with severe acute malnutrition randomized to receive
F100 or BP100, a ready-to-use food in biscuit form,
although children receiving BP100 had a significantly
higher energy intake. Finally, a double-blind, rando-
mized, placebo controlled efficacy trial investigated the
effect of adding probiotics and prebiotics to RUTF com-
pared to standard RUTF. The study found no significant
difference in the primary outcome, nutritional recovery,
or any of the secondary outcomes, including mortality.
HIV-infected children were at a higher risk of death in
both groups, but HIV did not confound or modify the
non-statistically significant effect of the intervention
[50].
We found very few rigorous trials that compared the
provision of therapeutic or supplementary foods to
other types of interventions aimed at modifying the
upstream factors that contribute to the development of
wasting. Fauveau [51] compared education on appropri-
ate complimentary feeding to education plus supple-
mentary feeding in children aged 6-12 months. The
supplementary food package contained rice, wheat, lentil
power and cooking oil. While the group receiving the
supplemental feeding package had a significantly higher
monthly weight gain at three months, this result was
not sustained at six months of follow-up.
A new randomized controlled trial comparing RUTF
to RUTF plus antibiotics (either amoxicillin or cefdinir)
in children with uncomplicated SAM in an outpatient
setting found that the mortality rate was significantly
higher in children receiving placebo than either antibio-
tic arm (amoxicillin RR: 1.55, 95% CI 1.07-2.24; cefdinir
RR: 1.80, 95% CI 1.22-2.64) [52]. The proportion of chil-
dren who recovered was significantly lower among the
placebo arm compared to either antibiotic arm (amoxi-
cillin: 3.6%, 95% CI 0.6-6.7; cefdinir: 5.8% lower, 95% CI
2.8-8.7), with no significant differences in death or
Figure 7 Forest plot for the effect of RUSF vs. CSB on weight gain in MAM
Figure 8 Forest plot for the effect of local vs. imported RUTF on weight gain in SAM
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recovery between the two antibiotic arms. Rates of
weight gain among children who recovered were higher
in the antibiotic arms compared to the placebo arm.
HIV status was not known for over half of the children
in the study. Additional studies are needed to strengthen
the evidence base on whether children with uncompli-
cated SAM should be provided routine antibiotics.
The Delphi process for establishing expert
consensus
Our review found limited high quality comparative trials
evaluating the package of care offered through commu-
nity-based management for uncomplicated SAM and
MAM. Additionally, studies of inpatient management of
SAM comparing the WHO protocol to standard care
tend to be observational without adjustment for con-
founding. Given the types of studies available and varying
contexts for many of these studies, we complemented the
systematic review with a Delphi process. The purpose of
the Delphi exercise was to gather and synthesize expert
opinion around the plausible impact estimates of inter-
ventions in various settings [53]. We invited both
researchers and practitioners who are experts in SAM
and MAM to participate and provided each expert with
summary data from our systematic review, details about
LiST, as well as specific instructions for the Delphi
process.
The Delphi consisted of three rounds. In the first
round, we asked experts to provide their best estimates
of CFR and recovery rate for inpatient and community
management of SAM. We also asked for CFR and
recovery rate for ‘optimal management’ of MAM and
asked each expert to provide his or her opinion on
which components constitute optimal management of
MAM.
We calculated the arithmetic mean and range for each
outcome and undertook thematic analysis of the qualita-
tive data. In the second round we provided each expert
with the means and ranges of each estimate, as well as a
summary of the themes for optimal management of
MAM. Experts were given the opportunity to refine
their point estimates and to comment on the summary
paragraphs. In the third round, we requested final com-
ments or edits on the Delphi sections presented in this
paper, and asked whether the experts wished to be
acknowledged in this paper.
Results from Delphi process
We received replies from 15 participants in round 1
(83%) and 13 participants responded to round 2 (72% of
total, 86% of round 1 participants). All participants pro-
vided input on what constitutes ‘optimal care’ of MAM;
13 participants contributed to the mortality and recov-
ery rates in each round.
For inpatient treatment of complicated SAM accord-
ing to the WHO protocol, the panel of experts estimate
a CFR of 14% (range: 5-30%) and recovery rate of 71%
(25-95%). The lower bound of the recovery rate is 25%
results from one expert who expressed that a large pro-
portion of admissions would default before recovery is
reached. For community-based treatment of SAM, the
CFR was estimated at 4% (range: 2-7%) and a recovery
rate was estimated at 80% (range: 50-93%). The mortal-
ity rate for MAM based on optimal treatment proposed
by the experts (see additional file 4) was estimated at 2%
(range: 0-4%) and recovery rate was 84% (50-100%).
Figure 9 Forest plot for the effect of impatient vs. ambulatory care on mortality in SAM
Table 4 Moderate and severe acute malnutrition: quality assessment of evidence at the category level
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It should be noted that true consensus in estimating
CFRs and morality rates was not achieved through this
process, as a few participants did not provide a single
estimate for each outcome, stating that the intervention
effects varied considerably by context. There was a con-
vergence of ideas around the general approach to mana-
ging MAM, as illustrated by the major themes described
in additional file 4. Consensus was not achieved regard-
ing whether all children with MAM (in areas of high
HIV prevalence) should be screened for HIV, the rela-
tive importance of each component of the management
approach, or the ideal form of food to provide (whether
there are other foods that are as effective as RUSF).
Discussion
The purpose of this review was to evaluate the effective-
ness of approaches to treating SAM, both the WHO
protocol for inpatient management and community-
based management using RUTF, as well as the effective-
ness of approaches to managing MAM. In all cases we
found fewer high quality studies than expected. We
were unable to conduct a pooled analysis comparing the
impact of the WHO protocol vs. standard care for the
treatment of SAM due to the type of studies available.
We conducted meta-analyses for community-based
management of SAM as well as management of MAM;
however, for the MAM analysis, the data available only
allowed us to pool studies comparing two food com-
modities. Thus, we were unable to adequately evaluate
the intervention effects separate from product effective-
ness. While there are limitations to both the review and
Delphi process that will be discussed subsequently, the
estimates generated from the literature review and sub-
sequently vetted through the Delphi process represent
the next step in modeling interventions to address SAM
and MAM in LiST.
The WHO protocol for the inpatient management of
SAM is substantiated through considerable evidence,
based both in research and expert opinion [1,54]. Sev-
eral studies have demonstrated that it is possible to
attain low CFRs. However, as illustrated by the lack of
high quality intervention studies, lack of adjustment for
confounding variables in observational studies, and
absence of key details in many publications, there is a
clear need for further research to improve our under-
standing of how to consistently achieve low CFRs across
varying resource-constrained settings.
The shift to outpatient care for the treatment of
uncomplicated SAM represents a major turning point in
the management of severe acute malnutrition, as is has
facilitated improved coverage and lower opportunity
costs to caregivers [55]. Community-based management
of severe acute malnutrition is backed by a wealth of
observational and programmatic data [55-57], yet we
found fewer impact studies than expected. While no sig-
nificant difference in mortality was found in our meta-
analysis, children given RUTF were 51% more likely to
achieve nutritional recovery in a timely manner, though
there was substantial heterogeneity. The differences in
anthropometric outcomes, while statistically significant,
were small and may not be clinically significant.
It should be noted that these pooled estimates were
based on two cohorts of children, both in Malawi, and
thus may not be generalizable. Additionally, HIV is an
important factor to consider given that the HIV preva-
lence rate of children with SAM in Sub-Saharan Africa
is high [58]. Unfortunately we were unable to disaggre-
gate the meta-analysis as only one trial tested for HIV.
A 2009 review that included children with SAM con-
cluded that HIV-infected children are significantly more
likely to die than HIV-uninfected children, but used a
broader definition of acute malnutrition [58]. Much
remains unclear about how to care for HIV-uninfected
children with SAM [59].
The results of our meta-analysis on community-based
treatment of MAM demonstrate that RUSF is slightly
more beneficial than CSB. Although statistically signifi-
cant, the higher rate of weight in the RUSF group is
small and may not be clinically important. Children in
the RUSF group were significantly more likely to recover
and less likely to be non-responders. However, these
estimates contained considerable levels of heterogeneity,
both in terms of study design and in terms of interven-
tion quality, which is poorly captured by most studies.
Furthermore, several individual studies that we were
unable to pool in our meta-analysis report modest or no
statistically significant difference in key nutritional out-
comes when comparing products [60-62]. There are sev-
eral dozen ongoing or planned studies focused on
demonstrating efficacy or effectiveness between or
among a range of possible food products and nutrient
supplements in the context of the management of
MAM, most of which will have reports in the upcoming
few years (personal communication CMAM Forum,
2012).
There are several limitations of this analysis. As some
of the participants in our Delphi process indicated, out-
comes of treatment programs are highly context specific
and depend on background rates of HIV, seasonal fluc-
tuations in food availability, and many other context-
specific variables. Additionally, the outcomes of the pro-
grams depend not only on the products used, but the
general quality of the program design and implementa-
tion, as has been noted by several researchers
[16,63-65]. Despite the importance of context, interven-
tion quality, and the linking of inpatient and outpatient
treatment programs along with preventive strategies, it
was not possible to undertake a disaggregated analysis
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by context, due to the limited number of trials available,
the lack of detail given on the interventions and analysis
in many studies, and the requirement for a single effect
estimate in LiST.
Further to the issues inherent in the analysis, there are
issues with individual studies that warrant discussion.
The diets given to children were often not described in
detail, and the amounts of CSB given to the comparison
group varied, sometimes including enough to share with
family members. Thus dietary intake of study partici-
pants is not clear in all cases. Furthermore, all but one
of the studies in the meta-analysis were conducted in
Africa, with a bias towards Malawi (see additional file
2), thus limiting the generalizability of the results. Addi-
tionally, all studies passively recruited participants who
were brought to treatment facilities. This may introduce
bias if there are systematic differences between care-
givers who are more likely, and those who are less likely,
to bring their children to facilities for treatment.
Directions for future research
Our review was unable to utilize a substantial propor-
tion of studies due to inconsistencies in admission cri-
teria, variability in the definition of acute malnutrition
(including the use of weight-for-age to assess nutritional
status), and irregularities in how data is reported. In
order to strengthen our understanding of the effective-
ness of interventions, through the use of meta-analysis,
there should be standard case definitions and reporting
of outcomes at standardized time intervals. Admission
criteria should be based on the WHO definition of
acute malnutrition, or children meeting these criteria
should be presented in a disaggregated analysis.
Further high quality impact studies of approaches to
managing SAM and MAM are needed. Particularly stu-
dies that reflect a broader range of settings where these
conditions are prevalent, including a range of geographic
locations and areas with different disease prevalence (i.e.
HIV). Though this area of research can present chal-
lenges for intervention studies, there are study design
options and data analysis techniques that allow for high
quality research. Where randomized controlled trials are
not feasible, another option would be to employ a
stepped-wedge design for research on community-based
management of SAM or MAM.
Our meta-analysis was constrained with respect to the
types of outcomes we were able to pool. Length of stay,
relapse (requiring re-admission to the hospital), default
rate, sustained recovery and cost-effectiveness were not
routinely measured, but are essential factors to consider
in program planning. Furthermore, all but one of the
studies included in this review follow children for a rela-
tively short period of time, providing little insight into
long-term effects. A recent follow-up study by Chang et
al. [66] found significant differences in sustained recov-
ery over 12-months of follow-up, depending on the
treatment given. Of all children successfully treated for
MAM, sustained recovery was significantly more likely
in those treated with soy/whey RUSF compared to those
treated with either soy RUSF or CSB++; however, the
authors concluded that all children in the study
remained vulnerable. More follow-up studies are needed
to illuminate long-term effects on developmental out-
comes, stunting, and the transition back to a home diet.
Standardized follow-up intervals over a longer time per-
iod, and reporting on a wider range of outcomes would
allow for higher quality meta-analyses and a more
robust understanding the intervention effects.
Similarly, trials are needed to compare different
approaches for the management of MAM that consider
local context, as a one-size-fits all approach is not
appropriate [67]. While food supplementation is neces-
sary in humanitarian emergencies and chronic food
insecurity, acute malnutrition is not confined to situa-
tions of conflict or famine [68]. In relatively more stable
situations, further research is needed on preventive
approaches that address upstream determinants of acute
malnutrition, illustrated by the range of ideas brought
forth in the Delphi exercise (see additional file 4).
As the body of literature grows, it will also be impor-
tant to disaggregate meta-analyses according to context.
Therefore, greater geographic representation is needed, as
are studies designed to explore the impact of factors that
likely affect the individuals’ treatment outcomes, such as
HIV status and household food insecurity, as well as stu-
dies that are designed to tease out the elements of suc-
cessful programs, beyond the choice of commodity.
Conclusions
The paradigm shift towards community-based treatment
of SAM has transformed the approach to treating acute
malnutrition. Community-based treatment is backed by
substantive programmatic evidence; however, there are
clear gaps in the availability of well-designed studies
evaluating the effectiveness of interventions to manage
SAM and MAM in a range of contexts. Thus, establish-
ing effect estimates for LiST proved challenging. The
meta-analysis demonstrates some positive effects of the
use of RUTF in comparison to CSB for the treatment of
SAM or MAM in the community; yet, the effects were
generally small and several outcomes had substantial
heterogeneity. Meanwhile, the results of the Delphi indi-
cate that the use of standardized protocols for treating
complicated SAM, uncomplicated SAM, and MAM,
should lead to low mortality and high recovery rates. To
close the gap between research and practice, further stu-
dies are needed that compare approaches to managing
SAM and MAM, taking local context into consideration.
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